Pharmacologic vitreolysis
Journal of Ophthalmic and Vision Research. 2010; 5 (1): 44-52
en Inglés
| IMEMR
| ID: emr-93269
ABSTRACT
The vitreoretinal interface is involved in a wide range of vitreoretinal disorders and separation of the posterior vitreous face from the retinal surface is an essential part of vitrectomy surgeries. A diverse range of enzymatic and non-enzymatic agents are being studied as an adjunct before or during vitrectomy to facilitate the induction of posterior vitreous detachment. There is a significant body of knowledge in the literature about different vitreolytic agents under investigation for a variety of pathologies involving the vitreoretinal interface which will be summarized in this review
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Vitrectomía
/
Cuerpo Vítreo
/
Activadores Plasminogénicos
/
Subtilisinas
/
Condroitinasas y Condroitín Liasas
/
Fibrinolisina
/
Desprendimiento del Vítreo
Límite:
Humanos
Idioma:
Inglés
Revista:
J. Ophthalmic Vision Res.
Año:
2010
Similares
MEDLINE
...
LILACS
LIS